We represent the views and interests of our members and industry generally to the UK government, the devolved administrations, regulators, other relevant third parties, including the media.
Medicines UK has members drawn from the generic medicines industry, who between them account for over 90% of the UK market by volume.
In everything that we do, we aim to promote an intellectual property, regulatory, pricing and market environment that enables the reasonable creation, development and sustainability of generic markets in the interests of members, patients and the United Kingdom National Health Service (NHS).